The Impact Of Ceftazidime-Avibactam Utilization In Hospital Setting
BACKGROUND: Ceftazidime-avibactam (CZA) represents a novel therapeutic approach for combating infections caused by multidrug-resistant Gram-negative bacteria. With the rise of antimicrobial resistance posing a significant challenge in hospital settings, this study aims to evaluate the utilization of...
Sparad:
| Huvudupphov: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Elsevier
2024-12-01
|
| Serie: | Journal of Global Antimicrobial Resistance |
| Ämnen: | |
| Länkar: | http://www.sciencedirect.com/science/article/pii/S2213716524002340 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
